Home Cart Sign in  
Chemical Structure| 107534-93-0 Chemical Structure| 107534-93-0

Structure of Macelignan
CAS No.: 107534-93-0

Chemical Structure| 107534-93-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Anwuligan, a natural product isolated and purified from the fruits of Schisandra chinensis, possesses therapeutic potentials against neurodegenerative diseases with oxidative stress and neuroinflammation.

Synonyms: (+)-Anwulignan; Anwuligan

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Macelignan

CAS No. :107534-93-0
Formula : C20H24O4
M.W : 328.40
SMILES Code : OC1=CC=C(C[C@H](C)[C@H](C)CC2=CC=C(OCO3)C3=C2)C=C1OC
Synonyms :
(+)-Anwulignan; Anwuligan
MDL No. :MFCD09953803

Safety of Macelignan

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
3×Transgene-AD mouse primary neuron cells 20 µM 24 hours To investigate the effect of Macelignan on Tau phosphorylation, results showed that Macelignan significantly reduced the phosphorylation levels of Tau at Ser 404 site Front Nutr. 2022 May 18;9:892558
N2a/SweAPP cells 0, 5, 10, 15, 20 µM 24 hours To investigate the effect of Macelignan on Aβ aggregation, results showed that Macelignan significantly reduced the expression levels of APP and Aβ Front Nutr. 2022 May 18;9:892558
HEK293/Tau cells 0, 5, 10, 15, 20 µM 24 hours To investigate the effect of Macelignan on Tau phosphorylation, results showed that Macelignan significantly reduced the phosphorylation levels of Tau at Ser 396, Ser 404, and Thr 231 sites Front Nutr. 2022 May 18;9:892558
SH-SY5Y/Tau cells 0, 5, 10, 15, 20 µM 24 hours To investigate the effect of Macelignan on Tau phosphorylation, results showed that Macelignan significantly reduced the phosphorylation levels of Tau at Ser 396, Ser 404, and Thr 231 sites Front Nutr. 2022 May 18;9:892558
MCF-7 cells 100 µM 144 hours To evaluate the effect of Macelignan on the proliferation of MCF-7 cells, results showed that 100 µM Macelignan increased cell proliferation to 201.07 ± 3.68% Pharmaceutics. 2021 Jul 15;13(7):1082
H9c2 cardiomyoblast cells 50 μM 22 hours To evaluate the protective effect of Macelignan against H2O2-induced oxidative stress, results showed that Macelignan significantly improved cell viability and reduced apoptosis Sci Rep. 2021 Jan 12;11(1):664
HepG2 cells 0–3 mM 48h Assess the cytotoxicity of Macelignan on HepG2 cells, showing low cytotoxicity. Braz J Med Biol Res. 2016 Jul 4;49(7):e5313
Ascosphaera apis 1.56 mg/mL (24h), 3.125 mg/mL (48h) 24h, 48h Evaluate the antifungal activity of Macelignan against Ascosphaera apis, showing significant growth inhibition. Braz J Med Biol Res. 2016 Jul 4;49(7):e5313
Streptococcus sanguinis 200 µg/ml 24 hours To evaluate the growth inhibitory effect of Macelignan on Streptococcus sanguinis, showing an inhibition zone diameter of 12.2±1.13 mm. Oral Health Prev Dent. 2020 Jul 4;18(3):537-542
Streptococcus mutans 200 µg/ml 24 hours To evaluate the growth inhibitory effect of Macelignan on Streptococcus mutans, showing an inhibition zone diameter of 11.8±0.67 mm. Oral Health Prev Dent. 2020 Jul 4;18(3):537-542

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice Chronic unpredictable mild stress (CUMS) model Intragastric administration 5 mg/kg Daily administration for 30 days Macelignan significantly improved CUMS-induced depression-like behaviors, including reduced immobility time in forced swimming and tail suspension tests. Additionally, Macelignan restored oxidative balance, suppressed neuroinflammation, and enhanced synaptic plasticity. Transl Psychiatry. 2025 May 9;15(1):163

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.05mL

0.61mL

0.30mL

15.23mL

3.05mL

1.52mL

30.45mL

6.09mL

3.05mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories